• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • español 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Login
Ver ítem 
  •   DSpace Principal
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Ver ítem
  •   DSpace Principal
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.
Todo DSpace
  • Comunidades & Colecciones
  • Por fecha de publicación
  • Autores
  • Títulos
  • Materias

Combination of rrt-pcr and anti-nucleocapsid/anti-spike antibodies to characterize specimens with very low viral sars-cov-2 load: A real-life experience

Thumbnail
Autor
Florou Z., Zigra M., Kartalidis P., Tsilipounidaki K., Papadamou G., Belia A., Fthenakis G.C., Petinaki E.
Fecha
2021
Language
en
DOI
10.3390/microorganisms9061263
Materia
MDPI AG
Mostrar el registro completo del ítem
Resumen
The objective of the present study was to evaluate the true positivity among people, whose results of initial testing of nasopharyngeal swabs (NPS) showed a very low viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Seventy-seven people detected with low viral loads of SARs-CoV-2 in nasopharyngeal samples (Ct ≥ 35) were enrolled in the study. For this purpose, a second NPS was collected for rRT-PCR (real-time reverse transcription polymerase chain reaction) combined with a pair of serum samples for detection of anti-nucleocapsid (anti-N) and anti-spike (anti-S) antibodies. In 8 people, subsequent examinations indicated an increase in viral loads, thereafter, followed by an increase of anti-N and anti-S antibodies, findings compatible with an early stage of COVID-19 infection. In 9 people, who already had increased anti-N antibodies, subsequent examination showed a decrease or absence of viral load and an increase in antibodies, indicative of a late stage of COVID-19 infection. In 60 people, subsequent examination showed absence of infection (as indicated by absence of viral load and antibodies). We propose that the combination of a second NPS and one serum-specimen, both taken three days after the first NPS, helps significantly to avoid false-positive results. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
URI
http://hdl.handle.net/11615/71626
Colecciones
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]
htmlmap 

 

Listar

Todo DSpaceComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasEsta colecciónPor fecha de publicaciónAutoresTítulosMaterias

Mi cuenta

AccederRegistro
Help Contact
DepositionAboutHelpContacto
Choose LanguageTodo DSpace
EnglishΕλληνικά
htmlmap